U.S. stock-index futures rose on Monday as investors' risk appetite improved as major global economies were returning to work amid slowing coronavirus infection rates. Meanwhile, Moderna's (MRNA; +27.9%) announcement of positive results from a Phase 1 clinical trial for its candidate Covid-19 vaccine stoked optimism about a potential coronavirus vaccine.
Global Stocks:
| Index/commodity | Last | Today's Change, points | Today's Change, % |
| Nikkei | 20,133.73 | +96.26 | +0.48% |
| Hang Seng | 23,934.77 | +137.30 | +0.58% |
| Shanghai | 2,875.42 | +6.96 | +0.24% |
| S&P/ASX | 5,460.50 | +55.70 | +1.03% |
| FTSE | 5,979.25 | +179.48 | +3.09% |
| CAC | 4,431.31 | +153.68 | +3.59% |
| DAX | 10,889.92 | +424.75 | +4.06% |
| Crude oil | $32.22 | | +9.48% |
| Gold | $1,742.00 | | -0.81% |